EXTON, PA — Frontage Europe, a wholly owned subsidiary of Frontage Laboratories Inc. (Nasdaq: FHL), has relocated its bioanalytical laboratory to a single, expanded facility near Milan, a move the company says will sharpen efficiency and streamline support for global clinical studies.
The newly consolidated laboratory spans approximately 2,500 square meters and brings Frontage Europe’s bioanalytical services under one roof, positioning the operation closer to key transportation infrastructure and pharmaceutical clients across Europe.
Company officials said the bioanalytical laboratory sits at the core of Frontage Europe’s service portfolio, featuring advanced platforms for quantitative mass spectrometry, ligand-binding assays, and biomarker analysis. The site is equipped with technologies including LC-MS/MS, Meso Scale Discovery, Quanterix Simoa HD-X, and ELISA assays, with recent expansion marked by the addition of a Lumipulse G1200 instrument.
The laboratory operates under a Good Laboratory Practice quality system and complies with Good Clinical Practice standards to support clinical research. Bioanalytical assay validation and sample analysis are conducted in accordance with international ICH M10 regulatory guidance, with additional expertise provided in pharmacokinetics and preparation of regulatory documentation such as investigator brochures and investigational new drug applications.
To meet growing client demand, Frontage Europe has also expanded its Central Lab services, adding logistics coordination and project management for clinical studies. The Milan-area facility is located roughly 25 kilometers from Malpensa Airport, a proximity the company said improves the movement of clinical samples and reduces logistical complexity.
The Central Lab offering is being further strengthened through targeted investments in analytical and sample-processing capabilities, along with expanded in-house cold storage, including minus 80-degree and minus 20-degree freezers.
Frontage said the relocation reflects a broader strategy to enhance operational efficiency while delivering integrated bioanalytical and clinical support services to pharmaceutical and biotechnology clients conducting studies across Europe and beyond.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.